Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
287,598,782
-
Share change
-
+6,675,313
-
Total reported value
-
$13,511,415,726
-
Put/Call ratio
-
83%
-
Price per share
-
$46.99
-
Number of holders
-
877
-
Value change
-
+$320,332,416
-
Number of buys
-
357
-
Number of sells
-
322
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2019
As of 31 Dec 2019 GLAXOSMITHKLINE PLC - ADR (GSK) had 877 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 287,598,782 shares of stock of the company.
Largest 10 holders included Dodge & Cox, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ROYAL BANK OF CANADA, STATE STREET CORP, Boston Partners, BANK OF AMERICA CORP /DE/, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This table shows 883 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.